The Philosophy of Evidence-based Medicine

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

ISBN: 9781405196673 | 140519667X
Cover: Paperback
Copyright: 4/25/2011

Buy New

Print on Demand: 2-4 Weeks. This item cannot be cancelled or returned.

$81.89

Evidence-based medicine (EBM) has become a required element of clinical practice, but it is critical for the healthcare community to understand the ongoing controversy surrounding EBM. Seeking to address questions raised by critics, The Philosophy of Evidence-based Medicine challenges the over dependency of EBM on randomized controlled trials. This book also explores EBM methodology and its relationship with other approaches used in medicine.

Acknowledgments	p. ix
Foreword	p. xi
Preface	p. xiii
Introduction
The philosophy of evidence-based medicine	p. 3
What on earth was medicine based on before evidence-based medicine?	p. 3
Scope of the book	p. 7
How the claims of EBM will be examined	p. 8
Structure of what is to come	p. 8
What is EBM?	p. 10
EBM as a self-proclaimed Kuhnian paradigm	p. 10
The motivation for the birth of EBM: a sketch	p. 11
Original definition of EBM	p. 15
Reaction to criticism of the EBM system of evidence: more subtle, more or less the same	p. 20
What is good evidence for a clinical decision?	p. 24
Introduction	p. 24
Evidence for clinical effectiveness	p. 25
Strong evidence tells us what?	p. 29
Do randomization, double masking, and placebo controls rule out more confounding factors than their alternatives?
Ruling out plausible rival hypotheses and confounding factors: a method	p. 33
Resolving the paradox of effectiveness: when do observational studies offer the same degree of evidential support as randomized trials?	p. 39
The paradox of effectiveness	p. 39
Observational studies: definition and problems	p. 40
Randomized trials to the rescue	p. 43
Defending the EBM view that randomized trials provide better evidence than observational studies	p. 48
Overcoming the paradox of effectiveness	p. 56
Conclusion: a more subtle way to distinguish between high- and low-quality comparative clinical studies	p. 59
types of restricted randomization	p. 60
Worrall's arguments that randomization is required for classical hypothesis testing and establishing probabilistic causes	p. 61
Questioning double blinding as a universal methodological virtue of clinical trials: resolving the Philip's paradox	p. 63
The problems with double masking as a requirement for clinical trial validity	p. 63
The many faces of double masking: clarifying the terminology	p. 65
Confounders that arise from participant and caregiver knowledge	p. 66
The importance of successful double masking	p. 69
One (and a half) solutions to the Philip's paradox	p. 75
The full solution to the Philip's paradox: challenging the view that double masking rules out confounding factors when treatments are evidently dramatic	p. 76
Double masking is valuable unless the treatment effects are evidently dramatic, hence the Philip's paradox does not arise	p. 78
Placebo controls: problematic and misleading baseline measures of effectiveness	p. 80
The need to control the placebo	p. 80
Legitimate placebo controls	p. 82
How placebo controls often violate the first condition for legitimacy	p. 83
How placebo controls often violate the second condition for legitimacy	p. 86
Special problem for constructing placebos for complex treatments: case studies of exercise and acupuncture	p. 87
Summary and solution to the problem with illegitimate placebo controls	p. 94
Questioning the methodological superiority of "placebo" over "active" controlled trials	p. 96
Epistemological foundations of the ethical debate over the use of placebo-controlled trials	p. 96
Problems with the assay sensitivity arguments against ACTs	p. 98
Problems with the first assay sensitivity argument against ACTs	p. 98
The second assay sensitivity argument	p. 106
Challenging the view that PCTs provide a measure of absolute effect size	p. 107
Questioning the claim that PCTs require smaller sample sizes	p. 112
Conclusion: a reassessment of the relative methodological quality of PCTs	p. 113
Appendix: more detailed explanation of why the second assay sensitivity argument fails	p. 114
Examining the paradox that traditional roles for mechanistic reasoning and expert judgment have been up-ended by EBM
Transition to Part III	p. 119
Summary of Part II	p. 119
Introduction to Part III	p. 120
A qualified defence of the EBM stance on mechanistic reasoning	p. 122
A tension between proponents of mechanistic reasoning and EBM views	p. 122
Clarifying the terminology: comparative clinical studies, mechanisms, and mechanistic reasoning	p. 124
Why the strong view that mechanistic reasoning is necessary to establish causal claims is mistaken	p. 130
Two epistemological problems with mechanistic reasoning	p. 136
Why EBM proponents should allow a more prominent role for high-quality (valid and based on "complete" mechanisms) mechanistic reasoning in their evidence hierarchies	p. 143
Mechanisms and other roles in clinical medicine	p. 146
Recommending a (slightly) more important role for mechanistic reasoning in the EBM system	p. 153
Appendix: cases where mechanistic reasoning led to the adoption of therapies that were either useless or harmful according to well-conducted clinical research	p. 154
Knowledge that versus knowledge how: situating the EBM position on expert clinical judgment	p. 158
Controversies surrounding the EBM stance on expert clinical judgement	p. 158
General clinical judgment belongs at the bottom of (or off) the hierarchy of evidence	p. 161
Individual clinical judgment also belongs at the bottom of the hierarchy	p. 167
The equally important non-evidential roles of expertise	p. 176
Conclusion	p. 182
Conclusions
Moving EBM forward	p. 187
Summary of findings: the EBM philosophy is acceptable, but. . .	p. 187
Two new frontiers for EBM	p. 189
References	p. 193
Index	p. 225
Table of Contents provided by Ingram. All Rights Reserved.

Please wait while the item is added to your bag...

FREE SHIPPING

Amazon no longer offers textbook rentals. We do!

The Philosophy of Evidence-based Medicine

Summary

Author Biography

Table of Contents

Supplemental Materials